NCT03565068
- Conditions
- Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
- Locations
-
- California Clinical Trials ( Site 0001) Glendale, California, United States
Clinical trial condition
Schizophrenia
Explore clinical trials studying Schizophrenia. Study availability and eligibility vary by location and protocol.
2,716 public trials
268 recruiting studies
Schizophrenia trial results
Completed
Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone
NCT00406315
- Conditions
- Mental Disorders, Psychotic Disorders, Schizoaffective Disorder, +2 more
- Locations
-
- Pfizer Investigational Site Phoenix, Arizona, United States
- Pfizer Investigational Site Costa Mesa, California, United States
- Pfizer Investigational Site Garden Grove, California, United States
- Pfizer Investigational Site National City, California, United States
NCT00174447
- Conditions
- Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
- Locations
-
- Pfizer Investigational Site Avignon, France
- Pfizer Investigational Site DOLE Saint YLIE, France
- Pfizer Investigational Site Liévin, France
- Pfizer Investigational Site Lyon, France
NCT02748694
- Conditions
- Healthy Volunteers, Mental Disorders, Schizophrenia, +1 more
- Locations
-
- Parexel Early Phase Clinic Unit- Los Angeles Glendale, California, United States
NCT00579670
- Conditions
- Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
- Locations
-
- Pfizer Investigational Site Athens, Greece
- Pfizer Investigational Site Chaïdári, Greece
- Pfizer Investigational Site Chaïdári, Greece
- Pfizer Investigational Site Chaïdári, Greece
NCT01053429
- Conditions
- Bipolar Disorder, Bipolar and Related Disorders, Mental Disorders, +3 more
- Locations
-
Not specified
NCT00139737
- Conditions
- Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
- Locations
-
- Pfizer Investigational Site Sora, Frosinone, Italy
- Pfizer Investigational Site Parma, PR, Italy
- Pfizer Investigational Site Acri, CS, Italy
- Pfizer Investigational Site Arezzo, Italy
NCT00723606
- Conditions
- Aberrant Motor Behavior in Dementia, Behavior, Behavioral Symptoms, +11 more
- Locations
-
- Pfizer Investigational Site Baoding, Hebei, China
- Pfizer Investigational Site Wuhan, Hubei, China
- Pfizer Investigational Site Kunming, Yunnan, China
- Pfizer Investigational Site Beijing, China
NCT04598906
- Conditions
- Behavior, Behavioral Symptoms, Cognition Disorders, +10 more
- Locations
-
- Mental Health Center Fryštát, Czechia
NCT02199743
- Conditions
- Mental Disorders, Psychotic Disorders, Schizoaffective Disorder, +2 more
- Locations
-
- UT Southwestern Medical Center Dallas, Texas, United States